New pill offers hope for PNH patients still anemic on standard therapy
NCT ID NCT06715943
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 18 times
Summary
This study tested an experimental pill called HRS-5965 in 39 adults with paroxysmal nocturnal hemoglobinuria (PNH) who remained anemic despite using standard anti-C5 antibody drugs. The goal was to see if the pill could raise hemoglobin levels without needing blood transfusions. Participants took the capsule for 24 weeks, and researchers measured blood counts and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL NOCTURNAL HEMOGLOBINURIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hematology Hospital of Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, 30000, China
-
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, 30000, China
Conditions
Explore the condition pages connected to this study.